Investor Toolbox
Read Transcript
Transcript not yet available.
View Infographic
Infographic not yet available.
BMRN Coverage
Event
BioMarin Pharmaceutical Inc (BMRN) BioMarin Presents New Data on the Positive Impact of Early Treatment With VOXZOGO (vosoritide) on Proportionality and Arm Span in Children with Achondroplasia at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting
Mar 12, 2026
Transcript
BioMarin Pharmaceutical Inc (BMRN) Q4 2025 Earnings Call Transcript
Mar 10, 2026
Event
BioMarin Pharmaceutical Inc (BMRN) Sec Form 10K
Feb 28, 2026
Event
BioMarin Pharmaceutical Inc (BMRN) U.S. Food and Drug Administration Approves BioMarin’s PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU)
Feb 27, 2026
Transcript
BioMarin Pharmaceutical Inc (BMRN) Q2 2025 Earnings Call Transcript
Jan 22, 2026
Transcript
BioMarin Pharmaceutical Inc (BMRN) Q3 2025 Earnings Call Transcript
Jan 22, 2026